We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

21 hedge funds and large institutions have $955K invested in Bio-Path Holdings Inc in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

11% more funds holding

Funds holding: 19 → 21 (+2)

35% less capital invested

Capital invested by funds: $1.47M → $955K (-$510K)

Holders
21
Holders Change
+2
Holders Change %
+10.53%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$409K
2
Citadel Advisors
Citadel Advisors
Florida
+$19.4K
3
TRCT
Tower Research Capital (TRC)
New York
+$9.29K
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.31K
5
UBS Group
UBS Group
Switzerland
+$920

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$39K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$350
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$335K +$307 +7 +0.1%
Walleye Capital
2
Walleye Capital
New York
$282K +$409K +9,340 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$101K -$350 -8 -0.2%
BlackRock
4
BlackRock
New York
$73.2K – – –
MYIA
5
Mount Yale Investment Advisors
Colorado
$38.3K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$29.9K +$19.4K +444 +81%
Renaissance Technologies
7
Renaissance Technologies
New York
$29K +$1.31K +30 +3%
Northern Trust
8
Northern Trust
Illinois
$26.7K +$876 +20 +2%
State Street
9
State Street
Massachusetts
$19.7K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$12K +$9.29K +212 +125%
UBS Group
11
UBS Group
Switzerland
$6.73K +$920 +21 +10%
Morgan Stanley
12
Morgan Stanley
New York
$1.06K – – –
MCC
13
Money Concepts Capital
Florida
$453 +$657 +15 New
Bank of America
14
Bank of America
North Carolina
$244 – – –
CA
15
Crewe Advisors
Utah
$106 – – –
GRP
16
Global Retirement Partners
California
$104 – – –
Wells Fargo
17
Wells Fargo
California
$74 – – –
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$21 -$6K -137 -17%
VF
19
Virtu Financial
New York
– -$39K -605 Closed
Simplex Trading
20
Simplex Trading
Illinois
– +$44 +1 New

BPTH Hedge Fund Activity: Q4 2022 in Review

21 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2022, worth a combined $955K — down 35% from $1.47M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BPTH positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Walleye Capital, opening a new position worth an estimated $409K. The largest seller was Virtu Financial, exiting entirely with an estimated $39K sold.

  • 21 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2022, up from 19 in Q3 2022.
  • Funds reported $955K of Bio-Path Holdings Inc stock for Q4 2022, down 35% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q4 2022 and 1 closed out, a net change of +2 holders.
  • The largest Bio-Path Holdings Inc buyer in Q4 2022 was Walleye Capital, an estimated $409K added.
  • The largest Bio-Path Holdings Inc seller in Q4 2022 was Virtu Financial, an estimated $39K sold.

Based on aggregated 13F filings for Q4 2022.